Immediate Impact
4 from Science/Nature 66 standout
Citing Papers
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
2024 Standout
Works of Shintaro Kanda being referenced
Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer
2019
Overcoming resistance to third-generation epidermal growth factor receptor tyrosine kinase inhibitor in non-small cell lung cancer
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Shintaro Kanda | 1247 | 1062 | 226 | 250 | 132 | 1.9k | |
| Fumihiko Hirai | 1103 | 961 | 209 | 426 | 101 | 1.8k | |
| Dwight H. Owen | 1295 | 622 | 303 | 276 | 110 | 1.8k | |
| Akihiro Tamiya | 1262 | 1177 | 176 | 277 | 107 | 1.8k | |
| Lorenzo Antonuzzo | 1273 | 575 | 397 | 308 | 166 | 1.8k | |
| Yusuke Okuma | 1499 | 890 | 253 | 527 | 184 | 2.4k | |
| Barbara Melosky | 1227 | 1085 | 134 | 380 | 114 | 2.0k | |
| Emily Z. Keung | 997 | 818 | 139 | 275 | 72 | 1.7k | |
| Shigeki Umemura | 1132 | 812 | 329 | 614 | 111 | 1.9k | |
| Renata Langfort | 568 | 853 | 157 | 258 | 124 | 1.6k | |
| Giuseppe Lo Russo | 1244 | 698 | 225 | 542 | 143 | 1.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...